157 related articles for article (PubMed ID: 22154438)
1. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement.
Nakanishi K; Miki A; Zaitsu K; Kamata H; Shima N; Kamata T; Katagi M; Tatsuno M; Tsuchihashi H; Suzuki K
Forensic Sci Int; 2012 Apr; 217(1-3):174-81. PubMed ID: 22154438
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
5. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays.
Begeman A; Franssen EJF
Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289
[TBL] [Abstract][Full Text] [Related]
6. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits.
Regester LE; Chmiel JD; Holler JM; Vorce SP; Levine B; Bosy TZ
J Anal Toxicol; 2015 Mar; 39(2):144-51. PubMed ID: 25492523
[TBL] [Abstract][Full Text] [Related]
7. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Stout PR; Klette KL; Horn CK
J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
[TBL] [Abstract][Full Text] [Related]
9. Screening for urinary amphetamine and analogs by capillary electrophoretic immunoassays and confirmation by capillary electrophoresis with on-column multiwavelength absorbance detection.
Ramseier A; Caslavska J; Thormann W
Electrophoresis; 1998 Nov; 19(16-17):2956-66. PubMed ID: 9870396
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens.
Hsu J; Liu C; Liu CP; Tsay WI; Li JH; Lin DL; Liu RH
J Anal Toxicol; 2003 Oct; 27(7):471-8. PubMed ID: 14607002
[TBL] [Abstract][Full Text] [Related]
11. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays.
Melanson SE; Lee-Lewandrowski E; Griggs DA; Long WH; Flood JG
Arch Pathol Lab Med; 2006 Dec; 130(12):1834-8. PubMed ID: 17149959
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines.
Kerrigan S; Mellon MB; Banuelos S; Arndt C
J Anal Toxicol; 2011 Sep; 35(7):444-51. PubMed ID: 21871153
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs.
Nieddu M; Burrai L; Trignano C; Boatto G
Leg Med (Tokyo); 2014 Mar; 16(2):106-9. PubMed ID: 24360925
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
Verstraete AG; Heyden FV
J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
[TBL] [Abstract][Full Text] [Related]
15. Screening for urinary amphetamine in truck drivers and drug addicts.
Pidetcha P; Congpuong P; Putriprawan T; Rekakanakul R; Suwanton L; Tantrarongroj S
J Med Assoc Thai; 1995 Oct; 78(10):554-8. PubMed ID: 8576663
[TBL] [Abstract][Full Text] [Related]
16. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
Lu NT; Taylor BG
Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
[TBL] [Abstract][Full Text] [Related]
17. Miniaturized sample preparation method for determination of amphetamines in urine.
Nishida M; Namera A; Yashiki M; Kimura K
Forensic Sci Int; 2004 Jul; 143(2-3):163-7. PubMed ID: 15240038
[TBL] [Abstract][Full Text] [Related]
18. Distribution of methamphetamine and amphetamine in drug abusers' head hair.
Lee S; Han E; Park Y; Choi H; Chung H
Forensic Sci Int; 2009 Sep; 190(1-3):16-8. PubMed ID: 19501481
[TBL] [Abstract][Full Text] [Related]
19. Performance of the Emit® II Plus 6-Acetylmorphine Assay on the Viva-E® analyzer.
Yau H; Dominowski A; Schaible C; Siefring G; Morjana N
Forensic Sci Int; 2012 Jul; 220(1-3):97-102. PubMed ID: 22410425
[TBL] [Abstract][Full Text] [Related]
20. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L
J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
